We work on addressing some of the world’s most immediate health threats including viral diseases such as Dengue Fever, Zika, Ebola and pandemic Flu, as well as serious intra-cellular bacterial infections, and we have a growing pipeline of vaccine candidates.
- Can One Vaccine Provide Immune Protection Against Multiple Pathogens? 27 July 2021
- T-cell priming vaccines offer the potential to provide faster, broader and longer lasting immunity to reduce serious illness associated with infectious diseases such as COVID-19. Here’s why… 27 July 2021
- Emergex Receives Regulatory Approval for a Phase I Clinical Trial in Dengue of a T-Cell Priming Vaccine 30 June 2021